Role of NFkappaB Signaling in Edothelial Dysfunction in Insulin Resistance
Role of NFkappaB Signaling in Edothelial Dysfunction in Insulin Resistance
批准号:
7156661
负责人:
SARA M REYNA
金额:
$5.2万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-01 至 2008-11-30
关键词:
antimetabolitesatherosclerosisbiological signal transductioncardiovascular disorder therapycardiovascular functionclinical researchenzyme inhibitorsexercisefree fatty acidshuman subjecthuman therapy evaluationinflammationinsulin sensitivity /resistancelymphocytemonocytenoninsulin dependent diabetes mellitusnuclear factor kappa betapathologic processpatient oriented researchpostdoctoral investigatorprotein kinasevascular endothelium
中文摘要
描述(申请人提供):大多数2型糖尿病(T2 DM)患者的死亡是由于动脉粥样硬化(1,2)。内皮功能障碍在糖尿病病程的早期发展,是动脉粥样硬化发展过程中最早可检测到的异常。T2 DM被认为是一种慢性低度炎症状态,细胞培养和动物研究的结果表明,循环单个核细胞(MNC)中炎症通路的活性增加有助于内皮功能障碍和动脉粥样硬化的发展。具体来说,由游离脂肪酸(FFA)、细胞因子和氧化应激激活的抑制物KKK/抑制KB(KB)/核因子KB(NFkB)通路诱导促炎分子的转录,这些分子参与了内皮功能障碍和动脉粥样硬化的发病机制。然而,目前尚不清楚T2 DM患者是否存在单核细胞IKK/kB/NFkB通路活性增加。我们将验证以下假设:T2 DM的内皮功能障碍与MNC中IKK/kB/NFkB通路的活性增加有关,以及Acipimox降低血浆FFA浓度将减少IKK/kB/NFkB信号并改善内皮功能。我们还将验证这样一种假设,即体育锻炼导致的内皮功能改善涉及IKK/kB/NFkB信号的减少。
英文摘要
DESCRIPTION (provided by applicant): Most deaths in subjects with type 2 diabetes mellitus (T2DM) are due to atherosclerosis (1,2). Endothelial dysfunction develops early in the course of diabetes, and is the earliest detectable abnormality in the development of atherosclerosis. T2DM is considered a state of chronic, low grade inflammation, and findings from cell culture and animal studies suggest that increased activity of inflammatory pathways in circulating mononuclear cells (MNC) contributes to the development of endothelial dysfunction and atherosclerosis. Specifically, the inhibitor KB kinase (IKK)/inhibitor kB (kB)/nuclear factor KB (NFkB) pathway, which is activated by free fatty acids (FFA), cytokines and oxidative stress, induces transcription of proinflammatory molecules that have been implicated in the pathogenesis of endothelial dysfunction and atherosclerosis. However, it is not known whether subjects with T2DM have increased activity of the IKK/kB/NFkB pathway in MNC. We will test the hypotheses that endothelial dysfunction in T2DM is associated with increased activity of the IKK/kB/NFkB pathway in MNC, and that a reduction in plasma FFA concentrations with Acipimox will reduce IKK/kB/NFkB signaling and improve endothelial function. We will also test the hypothesis that the improvement in endothelial function caused by physical training involves a decrease in IKK/kB/NFkB signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Macrophage ERK Signaling and Its Application in Modulating Skeletal Muscle Insulin Resistance
-
批准号:9888375
-
项目类别:
-
资助金额:$14.53万
-
财政年份:2018
-
负责人:SARA M REYNA
-
依托单位:
Role of NFkappaB Signaling in Edothelial Dysfunction in Insulin Resistance
-
批准号:7575127
-
项目类别:
-
资助金额:$2.45万
-
财政年份:2007
-
负责人:SARA M REYNA
-
依托单位:
Role of NFkappaB Signaling in Edothelial Dysfunction in Insulin Resistance
-
批准号:7330333
-
项目类别:
-
资助金额:$5.4万
-
财政年份:2007
-
负责人:SARA M REYNA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
卡路里限制的T细胞糖脂代谢重塑机制及网络调控
-
批准号:91957111
-
项目类别:重大研究计划
-
资助金额:80.0万元
-
批准年份:2019
-
负责人:李佩盈
-
依托单位:
高尿酸血症促进动脉粥样硬化机制探讨
-
批准号:81170251
-
项目类别:面上项目
-
资助金额:14.0万元
-
批准年份:2011
-
负责人:刘梅林
-
依托单位:
磷脂转运蛋白通过磷酸鞘氨醇1影响高密度脂蛋白抗动脉粥样硬化功能的分子机制
-
批准号:81070247
-
项目类别:面上项目
-
资助金额:33.0万元
-
批准年份:2010
-
负责人:秦树存
-
依托单位:
大麻素CB2受体:巨噬细胞efferocytosis功能调控和不稳定斑块防治的新靶点
-
批准号:81000086
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2010
-
负责人:江立生
-
依托单位:
抑制PI3K/Akt/mTOR/p70S6K 信号通路促进巨噬细胞自体吞噬稳定易损斑块的分子机制研究
-
批准号:30971216
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:陈文强
-
依托单位:
基因缺失突变抑制白细胞趋化稳定动脉粥样硬化易损斑块的研究
-
批准号:30871040
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2008
-
负责人:陈文强
-
依托单位: